The SOAR Study
- Project status: Active
Research area: Clinical Sciences > Brain and Mind > Genetics and Development
Aiming to understand life for adults with RASopathies like Noonan Syndrome and Neurofibromatosis type 1 (NF1).
Overview
RASopathies are a collection of related genetic conditions including Neurofibromatosis type 1 (NF1) and Noonan, Cardiofaciocutaneous (CFC), Costello, and Legius syndromes. While these conditions are most often diagnosed in childhood, they may continue to present health and psychosocial challenges throughout a person’s lifespan.
Purpose
The SOAR (Studying Outcomes in Adult RASopathies) Study aims to help researchers and clinicians who care for people with these genetic conditions understand what it’s like to live with them in adulthood.
This research is important as it will help identify areas of health and general life that may be challenging for some adults with RASopathies, which may improve clinical care.
Get involved
If you are an adult aged 18 to 65 with a RASopathy living in Australia or the UK, you can participate in the online SOAR study.
You will be asked to complete a series of online questionnaires that ask about physical and mental health as well as quality of life. Participation may take up to two hours across two sets of questionnaires. You may choose to complete one or both sets.
After participating, you may also choose to nominate a relative and/or a significant other (such as a partner or carer) to join in the study with you and answer some questions on their own.
If you are a relative or significant other and would like to participate without a nomination from the person with a RASopathy due to a special circumstance, please contact our team via email to discuss.
Find out more or register for the study:
Lead researchers
| Team member | Organisation |
|---|---|
| Associate Professor Jonathan Payne | Murdoch Children's Research Institute, The Royal Children's Hospital, University of Melbourne |
| Dr Shruti Garg | The University of Manchester |
| Dr Emma Burkitt-Wright | The University of Manchester |
| Professor Kate Drummond | Royal Melbourne Hospital |
| Dr Natalie Pride | The Children's Hospital at Westmead |
| Associate Professor Yemima Berman | Royal North Shore Hospital |
Research team
| Team member | Organisation |
|---|---|
| Dr Kristina Haebich | Murdoch Children's Research Institute, The Royal Children's Hospital, University of Melbourne |
| Professor David Coghill | Murdoch Children's Research Institute, The Royal Children's Hospital, University of Melbourne |
| Ms Alice Maier | Murdoch Children's Research Institute, The Royal Children's Hospital, University of Melbourne |
| Dr Nicholas Ryan | Murdoch Children's Research Institute, Deakin University |
| Dr Gabriel Dabscheck | Murdoch Children's Research Institute, The Royal Children's Hospital, University of Melbourne |
| Dr Chloe Cunningham | Murdoch Children's Research Institute, Victorian Clinical Genetics Service |
| Dr Jane Fleming | Royal North Shore Hospital |
Thanks to our key partners, funders, and supporters.
Funding
Participating sites
- Murdoch Children’s Research Institute
- The Royal Children’s Hospital
- Royal Melbourne Hospital
- The Children’s Hospital at Westmead, Sydney, Australia
- Royal North Shore Hospital, Sydney, Australia
- Manchester Centre for Genomics Medicine, Manchester, United Kingdom
Contact us
The SOAR Study
Murdoch Children's Research Institute
The Royal Children's Hospital
50 Flemington Road
Parkville VIC 3052
Australia
Email: show email address
Neurofibromatosis type 1 (NF1) newsroom
Flicker of Hope – Kicking Butt 2023
Established in 2018, the Flicker of Hope Foundation shines a light on Neurofibromatosis (NF) by...
Neurofibromatosis type 1 (NF1)
Neurofibromatosis type 1 is a genetic condition arising from a gene mutation that causes tumours...
Funding boost for research into genetic disorder that causes nerve tumours
Two Murdoch Children's Research Institute (MCRI) projects have received funding for...
Clinical trial testing new treatment for childhood cancer receives funding boost
A clinical trial testing whether a cancer drug can shrink tumours in children with a common...
Share //
